Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
Zobair M. Younossi, Kathleen E. Corey, Joseph K. Lim
Gastroenterology (2020) Vol. 160, Iss. 3, pp. 912-918
Closed Access | Times Cited: 362

Showing 26-50 of 362 citing articles:

Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects
Yuji Xiao, Xuefei Xiao, Xue Zhang, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 207-220
Closed Access | Times Cited: 21
Nutrition Assessment and Management in Celiac Disease
María Inés Pinto-Sánchez, Jedid-Jah Blom, Peter R. Gibson, et al.
Gastroenterology (2024)
Closed Access | Times Cited: 18
Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management
Daniel Simancas‐Racines, Giuseppe Annunziata, Ludovica Verde, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai–Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 3
The growing range of complications of diabetes mellitus
Peter Shane Hamblin, Anthony Russell, Stella Talic, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 2
Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
Meijing Chen, Ying Chen, Jin-qing Lin, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 2
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States
Saleh A. Alqahtani, James M. Paik, Rakesh Biswas, et al.
Hepatology Communications (2021) Vol. 5, Iss. 11, pp. 1833-1847
Open Access | Times Cited: 88
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Marco Arrese, Juan Pablo Arab, Francisco Barrera, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 04, pp. 421-434
Open Access | Times Cited: 79
Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
Stergios A. Pοlyzos, Stergios Kechagias, Emmanuel Tsochatzis
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 8, pp. 1013-1025
Open Access | Times Cited: 79
Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Veera Houttu, Susanne Csader, Max Nieuwdorp, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 73
Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis
Ambrin Farizah Babu, Susanne Csader, Johnson Lok, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3135-3135
Open Access | Times Cited: 72
Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice
Jingjing Duan, Zhuo Wang, Ran Duan, et al.
Hepatology (2021) Vol. 75, Iss. 1, pp. 140-153
Open Access | Times Cited: 69
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 67
Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH
Gavin Fredrickson, Fanta Barrow, Katrina Dietsche, et al.
Molecular Metabolism (2021) Vol. 53, pp. 101270-101270
Open Access | Times Cited: 59
Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life
Zobair M. Younossi, Maria Stepanova, Rebecca Taub, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 6, pp. 1354-1361.e7
Closed Access | Times Cited: 57
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S43-S57
Open Access | Times Cited: 57
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 53
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Ajay Duseja, Shivaram Prasad Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 2, pp. 273-302
Open Access | Times Cited: 53
Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease
Laura E. Dichtel, José Córdoba‐Chacón, Rhonda D. Kineman
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1812-1824
Open Access | Times Cited: 52
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
Zobair M. Younossi, James M. Paik, Linda Henry, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 3, pp. 454-467
Open Access | Times Cited: 40
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
Thomas Marjot, Jeremy Tomlinson, Leanne Hodson, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1607-1619
Open Access | Times Cited: 39
Management of metabolic-associated fatty liver disease: The diabetology perspective
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 126-143
Open Access | Times Cited: 34
Pathogenesis of Hypertension in Metabolic Syndrome: The Role of Fructose and Salt
Manoocher Soleimani, Sharon Barone, Henry Luo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4294-4294
Open Access | Times Cited: 32
Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use
Melinda H. Spooner, Donald Β. Jump
Annual Review of Nutrition (2023) Vol. 43, Iss. 1, pp. 199-223
Open Access | Times Cited: 28
Seaweed-Derived Sulfated Polysaccharides; The New Age Chemopreventives: A Comprehensive Review
Prajna Paramita Bhuyan, Rabindra Nayak, Srimanta Patra, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 715-715
Open Access | Times Cited: 26

Scroll to top